6675 Part 2 Flashcards

1
Q

__________________ shall take the necessary steps to ensure that all drugs authorized for marketing in the country shall conform to
international standards for the content, purity and quality of
pharmaceutical products as established in the International Pharmacopoeia:

A

BFAD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

imported products in finished dosage forms, should be certified under the __________________ certification scheme on the quality of pharmaceutical products moving in international commerce

A

World Health Organization (WHO)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

registration for multisource pharmaceutical products should conform to the ______________ on registration requirements to establish interchangeability

A

WHO guidelines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

refers to pharmaceutically equivalent or pharmaceutically alternative products that may or may not be therapeutically equivalent

A

Multisource pharmaceutical products

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

T/F: Multisource pharmaceutical products that are therapeutically equivalent are interchangeable

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

T/F: Medicinal products are pharmaceutically equivalent if they contain the same amount of the same active substance(s) in the same dosage forms
that meet the same or comparable standards.

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

T/F: Pharmaceutical equivalence does not necessarily imply bioequivalence

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

are medicinal products with different salts, esters, ethers, isomers, mixtures of isomers, complexes or derivatives of an active moiety, or which differ in dosage form or strength.

A

Pharmaceutical alternatives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Two pharmaceutical products are therapeutically equivalent if they are ___________________ and, after administration in the same molar dose, their effects with respect to both efficacy and safety are essentially the same, as determined from appropriate bioequivalence, pharmacodynamic, clinical, or in vitro studies.

A

pharmaceutically equivalent or alternatives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

A contract between government with innovator. In return for disclosing the invention to the public, the innovator receives the right to exclude others from practicing the invention for a limited period of time.

A

RIGHT TO MAKE AVAILABLE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Right to make available is typically ___________ from filing the patent application

A

20 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Can discoveries, scientific theories, and mathematical methods be patented?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

T/F: Mere discovery of a new form or property of a known substance is not patentable if it doesn’t enhance the known substance’s efficacy.

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

T/F: Mere discovery of any new property or use for a known substance is not patentable.

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

T/F: Mere use of a known process is not patentable unless it results in a new product with at least one new reactant.

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

T/F: Various derivatives of a known substance (salts, esters, ethers, polymorphs, metabolites, pure form, particle size, isomers, mixtures of isomers, complexes, combinations, etc.) are considered the same substance unless they significantly differ in efficacy-related properties.

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What conditions allow a government agency or third party authorized by the government to exploit an invention without the agreement of the patent owner, specifically concerning drugs and medicines in the Philippines?

A

national emergency, public non-commercial use, demand for patented article is not being met

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

___________may grant a license to exploit a patented invention, even without the agreement of the patent owner, in favor of any person who has shown his capability to exploit the invention

A

The Director General of the Intellectual Property Office

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Under what circumstance can the Director General of Intellectual property exploit a patented invention?

A

demand for patented drugs and medicines is not being met to an adequate extent and on reasonable terms, as determined by the Secretary of the Department of Health

20
Q

T/F: It shall be unlawful for any retail drug outlet to refuse to carry either by
sale or by consignment, or offer for sale drugs and medicines brought into
the country by the government or authorized third party which have been previously approved for distribution or sale by the Bureau of Food and Drugs

A

True

21
Q

products brought into the country by government or authorized third party shall be displayed with equal prominence as all other products sold in the establishment

A

True

22
Q

____________ shall have the power to impose maximum retail prices over any or all drugs and medicines

A

President of the Philippines (upon recommendation of the Secretary of the Department of Health)

23
Q

____________ authorized to establish and initiate a price monitoring and regulation system for drugs and medicines within ____________ days after the enactment of this Act.

A

Secretary of the Department of Health; 120 days

24
Q

____________ may also create such bodies, consultative councils, from which advice may be sought in the implementation of a drug or medicine price monitoring and regulation policy

A

Secretary of the Department of Health

25
Q

List of Drugs that are subject to price regulation:

A
  1. chronic illnesses and life threatening conditions
  2. indicated for prevention of diseases
  3. indicated for prevention of pregnancy
  4. Anesthetic agents
  5. Intravenous fluids
  6. included in the Philippine National Drug Formulary (PNDF) Essential Drug List
  7. determined by Sec of DOH
26
Q

Drugs and medicines for treatment of chronic illnesses and life threatening conditions, such as, but not limited to:

A

a) endocrine disorders
b) gastrointestinal disorders
c) urologic disorders
d) cardiovascular diseases
e) pulmonary diseases
f) auto-immune diseases
g) skin diseases
h) neuro-psychiatric disorders
i) other infectious diseases, and other conditions such as organ transplants and neoplasm;

27
Q

Criteria for recommending MRP

A

Retail prices
Supply available
Cost to the manufacturer, importer, trader, distributor, wholesaler, or
retailer

28
Q

T/F: labels under MDRP Control must include “Under Drug Price Regulation Retail Price Not To Exceed” in red font/red background

A

True

29
Q

RA _______ = Cheaper and Quality Medicines

A

9502

30
Q

RA 9502 ammends RAs ________, _________, ____________

A

8293, 6675, 5921

31
Q

RA 8293 is also called as

A

intellectual property code

32
Q

The consumer act of the philippines

A

RA 7394

33
Q

Price Act

A

RA 7581

34
Q

this act states that:
Develop, adopt and promulgate measures to promote productivity in basic necessities and prime commodities;

A

RA 7581

35
Q

this act states that:
Develop an improved and efficient transport and distribution system;

A

RA 7581

36
Q

Develop, adopt and promulgate measures to stabilize prices at reasonable levels;

A

RA 7581

37
Q

Institute appropriate penalties for illegal price manipulation and other violations of this Act and

A

RA 7581

38
Q

Establish a mechanism that will readily protect consumers from inadequate supply and unreasonable price increases on occasions of calamities, emergencies and like occurrences.

A

RA 7581

39
Q

T/F: hoarding, profiteering, or illegal combination or forming cartel is considered illegal by RA 7581

A

True

40
Q

the undue accumulation by a person or combination of persons of any basic necessity or prime commodity beyond his or their normal inventory levels or the unreasonable limitation or refusal to dispose of, sell or distribute the stocks of any basic necessity or prime commodity to the general public or the unjustified taking out of any basic necessity or prime commodity from the channels of production, trade, commerce, and industry.

A

Hoarding

41
Q

commodity from the channels of production, trade, commerce, and industry. There shall be prima facie evidence of hoarding when a person has stocks of any basic necessity or prime commodity _______________ higher than his usual inventory and unreasonably limits, refuses or fails to sell the same to the general public at the time of discovery of the stocks

A

fifty percent (50%)

42
Q

which is the sale or offering for sale of any basic necessity or prime commodity at a price grossly in excess of its true worth

A

Profiteering

43
Q

There shall be prima facie evidence of profiteering whenever a basic necessity or prime commodity being sold (profiteering):

A

has no price tag;
is misrepresented as to its weight or measurement;
is adulterated or diluted; or
whenever a person raises the price of any basic necessity or prime commodity he sells or offers for sale to the general public by more than ten percent (10%)

44
Q

which is any combination of or agreement between two (2) or more persons engaged in the production, manufacture, processing, storage, supply,
distribution, marketing, sale or disposition of any basic necessity or prime commodity designed to artificially and unreasonably increase or manipulate its price.

A

Cartel

45
Q

There shall be prima facie evidence of engaging in a cartel whenever _________ persons or business enterprises competing for the same market and dealing in the same basic necessity or prime commodity, perform uniform or complementary acts among themselves which tend to bring about artificial and unreasonable increase in the price of any basic necessity or prime commodity or when they simultaneously and unreasonably increase prices on their competing products thereby lessening competition among themselves

A

two (2) or more

46
Q

Penalty for Illegal Acts of Price Manipulation.

A
  • imprisonment for a period of not less than five (5) years but not more than fifteen (15) years, or
  • fine of not less than Php100,000.00 but not more than Php10,000,000.00, at discretion court.
  • The court may also order the suspension or revocation of LTO, professional or business license